NasdaqCM - Nasdaq Real Time Price USD
Akari Therapeutics, Plc (AKTX)
1.3200
-0.0200
(-1.49%)
As of 10:26:18 AM EDT. Market Open.
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
50,562
--
13,832
11,648.0280
Total Liabilities Net Minority Interest
28,333
--
12,041
6,093.4460
Total Equity Gross Minority Interest
22,229
--
1,791
5,554.5820
Total Capitalization
22,229
--
1,791
5,554.5820
Common Stock Equity
22,229
--
1,791
5,554.5820
Net Tangible Assets
-25,381
--
1,774
5,531.6530
Working Capital
-16,958
--
1,774
5,531.6530
Invested Capital
25,489
--
1,791
5,554.5820
Tangible Book Value
-25,381
--
1,774
5,531.6530
Total Debt
3,260
--
--
--
Net Debt
661
--
--
--
Share Issued
53,186,919.5230
13,234,315.2980
7,444,917.1230
4,759,731.9230
Ordinary Shares Number
53,186,919.5230
13,234,315.2980
7,444,917.1230
4,759,731.9230
12/31/2021 - 1/6/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
XBIO Xenetic Biosciences, Inc.
3.0000
-4.76%
VTVT vTv Therapeutics Inc.
20.72
-2.49%
IKNA Ikena Oncology, Inc.
1.1000
+1.85%
ABS.OL Arctic Bioscience AS
2.6000
-8.13%
TENX Tenax Therapeutics, Inc.
5.79
+1.85%
ELIC.ST Elicera Therapeutics AB (publ)
5.07
+15.23%
BTTX Better Therapeutics, Inc.
0.0002
0.00%
BPTH Bio-Path Holdings, Inc.
0.1631
-14.16%
GNMSF Genmab A/S
209.05
0.00%
LVTX LAVA Therapeutics N.V.
1.2214
-3.83%